SERA PROGNOSTICS, INC. Logo

SERA PROGNOSTICS, INC.

Develops predictive blood tests to assess preterm birth risk and improve pregnancy outcomes.

SERA | US

Overview

Corporate Details

ISIN(s):
US81749D1072
LEI:
Country:
United States of America
Address:
2749 E. PARLEYS WAY, 84109 SALT LAKE CITY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sera Prognostics, Inc., also known as The Pregnancy Company®, is a women's health diagnostics company focused on improving maternal and neonatal health through precision pregnancy care. The company utilizes proteomics and bioinformatics to develop and commercialize predictive biomarker tests. Its flagship product, the PreTRM® Test, is a blood-based test that predicts an individual's risk of spontaneous preterm delivery. Sera also offers the LikeMine™ platform, which provides data-driven pregnancy insights for mothers. By delivering pivotal information to physicians, payers, and patients, Sera aims to improve health outcomes and economics in prenatal care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SERA PROGNOSTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SERA PROGNOSTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SERA PROGNOSTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Tempest Therapeutics, Inc. Logo
Clinical-stage oncology company developing oral small molecule therapeutics to treat cancer.
United States of America
TPST
TENAX THERAPEUTICS, INC. Logo
Clinical-stage pharma developing novel therapies for cardiovascular and pulmonary diseases.
United States of America
TENX
Teva Pharmaceutical Industries Ltd. Logo
A leader in affordable generic drugs and innovative specialty treatments for complex diseases.
Israel
TEVA
Tevogen Bio Holdings Inc. Logo
Developing precision, off-the-shelf T cell therapies for cancer, infections, and neuro disorders.
United States of America
TVGN
TG THERAPEUTICS, INC. Logo
Commercializes B-cell therapies like BRIUMVI® for multiple sclerosis & autoimmune diseases.
United States of America
TGTX
Tharimmune, Inc. Logo
Clinical-stage biotech developing therapies for immunology, oncology, & opioid effects.
United States of America
THAR
THERAGEN ETEX CO.,LTD. Logo
A biotech firm offering gene analysis and developing personalized cancer drugs.
South Korea
066700
Theratechnologies Inc. Logo
Biopharma company commercializing therapies for multi-drug resistant HIV and lipodystrophy.
United States of America
THTX
Theravance Biopharma, Inc. Logo
Developing medicines for specialty respiratory and neurologic diseases like COPD.
United States of America
TBPH
TheraVet SA Logo
Belgium
ALVET

Talk to a Data Expert

Have a question? We'll get back to you promptly.